Standard of Excellence: Engineering Collaboration Has Become the New Sales Strategy
Bridging the Pacific: Why Global Manufacturing Is No Longer Optional
Knocking Down the Bone Pile: Minimizing X-ray Dosage During PCB Inspection
Nordson Corporation has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical.
“This divestiture allows Nordson MEDICAL to focus on its higher value growth opportunities within our $800 million medical and fluid solutions segment. This includes our growing portfolio of proprietary medical components, including balloons, cannula, nitinol devices and the recently acquired Atrion products,” said Justin Hall, executive vice president, Nordson Medical and Fluid Solutions segment. “We are confident that our contract medical design and development business will thrive under Quasar’s leadership, and we expect a smooth transition for our customers.”
